Déborah Heintze pushes the boundaries of tissue analytics and develops machines that improve diagnostic tests for cancer.
She completed a Bachelor's degree in Life Sciences and Technology and a Master's degree in Bioengineering at the Federal Institute of Technology Lausanne. During a year at the Harvard-MIT Division of Health Sciences and Technology in Boston, USA, she developed a device for testing drugs on cardiac tissues. In 2013, she co-founded Lunaphore, a company that analyses tissue in-situ for cancer research. This company develops automated analysis systems based on microfluidic technology, which allows for faster and more precise analysis. This cutting-edge technology has earned Lunaphore many prestigious accolades.
La version française suivra sous peu.
Die deutsche Fassung folgt kurzum.
La versione italiana seguirà a breve.
La versión española pronto estará disponible.